Zohar Zisapel
Angel Investor
Tel Aviv, Israel
Zohar Zisapel is a Series A investor in Tel Aviv focused on Cyber Security and Security. Zohar Zisapel is the Founder of RAD Data Communications. He previously worked at Argus Cyber Security as a Co-Founder & Chairman. Zohar Zisapel attended Tel Aviv University.
- Total investments:
- 27
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries Zohar Zisapel invests in
Stages Zohar Zisapel invests in
Countries Zohar Zisapel invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $3M–$26M
- Series A
- $7M–$17M
- Series B
- $15M–$65M
Investment Focus
Industry
- Cyber Security 7 (26%)
- Security 5 (19%)
- Software 5 (19%)
- Information Technology 4 (15%)
- Automotive 3 (11%)
Stage
- Series A 9 (33%)
- Seed 6 (22%)
- Series B 6 (22%)
- Series C 1 (4%)
- Venture - Series Unknown 1 (4%)
Country
- Israel 12 (44%)
- United States 3 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Hailo is an Israel-based deep learning company that develops a breakthrough specialized deep learning microprocessor to deliver data center performance to edge devices. The company aims to drive artificial intelligence to the edge. Its processors enable edge devices to go beyond handling sensors and streaming volumes of data for remoteprocessing–they can do the processing themselves.Hailo’s complete re-think of computer architecture breaks the barriers of traditional paradigms, accelerating the extremely heavy computation of deep neural networks. | $120M / Series C / Apr 02, 2024 | ||
| Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation patterns. Nucleix offers a urine test for monitoring of bladder cancer called Bladder EpiCheck and a blood test for early detection of lung cancer called LungEpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel. | $22M / Venture - Series Unknown / Jan 05, 2022 | ||
| Cylus was founded to help mainline and urban railway companies avoid safety incidents and service disruptions caused by cyber-attacks. Cylus offers solutions that are specifically designed to address the unique requirements and needs of the railway industry, enabling to detect cyber threats in signaling and control networks, trackside andonboard, facilitating an effective response before harm happens. Led by veterans from the elite technological unit of the Israel Defense Forces’ Intelligence Corps, together with top executives from the railway industry, Cylus’ team combines deep expertise in cybersecurity and rail. | $30M / Series B / Dec 15, 2021 | ||
| Hailo is an Israel-based deep learning company that develops a breakthrough specialized deep learning microprocessor to deliver data center performance to edge devices. The company aims to drive artificial intelligence to the edge. Its processors enable edge devices to go beyond handling sensors and streaming volumes of data for remoteprocessing–they can do the processing themselves.Hailo’s complete re-think of computer architecture breaks the barriers of traditional paradigms, accelerating the extremely heavy computation of deep neural networks. | $136M / Series C / Oct 12, 2021 | ||
| Talon Cyber Security is a provider of cybersecurity solutions for the distributed workforce. A next-generation solution designed to protect against a new category of threats posed by distributed work, Talon enables workforce productivity and flexibility alongside rock-solid cybersecurity. It delivers the industry’s first secure browser designed tobring enterprise-grade security to managed and unmanaged devices, regardless of location, device type, or operating system. | $26M / Seed / Apr 11, 2021 | ||
| Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation patterns. Nucleix offers a urine test for monitoring of bladder cancer called Bladder EpiCheck and a blood test for early detection of lung cancer called LungEpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel. | $55M / Venture - Series Unknown / Apr 07, 2021 | ||
| Cylus was founded to help mainline and urban railway companies avoid safety incidents and service disruptions caused by cyber-attacks. Cylus offers solutions that are specifically designed to address the unique requirements and needs of the railway industry, enabling to detect cyber threats in signaling and control networks, trackside andonboard, facilitating an effective response before harm happens. Led by veterans from the elite technological unit of the Israel Defense Forces’ Intelligence Corps, together with top executives from the railway industry, Cylus’ team combines deep expertise in cybersecurity and rail. | $10M / Series A / Dec 09, 2020 | ||
| Autonomous Low Speed Vehicle | $6.5M / Seed / Sep 20, 2020 | ||
| Hi Auto builds a Conversational AI for the restaurants world with a focus on automated drive thru ordering. Our unique technology of Speech Recognition in very noisy environment and NLU built from the ground up allows us to handle very complex conversations in noisy environments. | $8M / Seed / Jul 01, 2020 | ||
| The DriveU.auto connectivity platform enables teleoperation of autonomous vehicles using cellular bonding and dynamic encoding. The platform is already deployed and used live on public roads. It provides high speed, low latency, and ultra-reliable transmission of 4k video, audio streams, high-speed data, and control channels, and is available withhardware, or as a software-only implementation. The platform’s SDK and APIs enable quick and straightforward integration. | $4M / Seed / Jun 23, 2020 | ||
| See all 27 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Zohar Zisapel invest in?
Zohar Zisapel invests primarily in Cyber Security, Security and Software startups, most often at Series A and Seed stage. Most of the 27 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Zohar Zisapel's check size?
Zohar Zisapel typically joins rounds of $3M–$26M at Seed, $7M–$17M at Series A and $15M–$65M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Zohar Zisapel participates in.
How do I contact Zohar Zisapel?
Public channels for Zohar Zisapel include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Zohar Zisapel last invest?
The most recent investment recorded for Zohar Zisapel closed in Apr 2024. Shizune tracks 27 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
